Fibroblast growth factor receptor 2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma-Reference-Cited by-同舟云学术

Fibroblast growth factor receptor 2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma

Published:2014-02-18 Issue:4 Volume:59 Page:1427-1434
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Arai Yasuhito¹,Totoki Yasushi¹,Hosoda Fumie¹,Shirota Tomoki¹,Hama Natsuko¹,Nakamura Hiromi¹,Ojima Hidenori²,Furuta Koh³,Shimada Kazuaki⁴,Okusaka Takuji⁵,Kosuge Tomoo⁴,Shibata Tatsuhiro¹

Affiliation:

1. Division of Cancer Genomics; National Cancer Center Research Institute; Tokyo Japan

2. Division of Molecular Pathology; National Cancer Center Research Institute; Tokyo Japan

3. Department of Clinical Laboratories; National Cancer Center Hospital; Tokyo Japan

4. Department of Hepatobiliary and Pancreatic Surgery; National Cancer Center Hospital; Tokyo Japan

5. Department of Hepatobiliary and Pancreatic Oncology; National Cancer Center Hospital; Tokyo Japan

Funder

National Cancer Center Research Development Funds

National Institute of Biomedical Innovation

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.26890/fullpdf

Reference26 articles.

1. Classification, diagnosis, and management of cholangiocarcinoma;Razumilava;Clin Gastroenterol Hepatol,2013

2. Cholangiocarcinoma;Khan;Lancet,2005

3. Exome sequencing of liver fluke-associated cholangiocarcinoma;Ong;Nat Genet,2012

4. Molecular profiling of cholangiocarcinoma shows potential for targeted therapy treatment decisions;Voss;Hum Pathol,2013

5. Systemic therapy for biliary tract cancers;Hezel;Oncologist,2008

Cited by 450 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of S-adenosylhomocysteine hydrolase-like 1 in cancer;Biochimica et Biophysica Acta (BBA) - Molecular Cell Research;2024-10

2. Chinese national clinical practice guideline on diagnosis and treatment of biliary tract cancers;Chinese Medical Journal;2024-09-04

3. Design, synthesis and biological evaluation of 5-amino-1H-pyrazole-4-carboxamide derivatives as pan-FGFR covalent inhibitors;European Journal of Medicinal Chemistry;2024-09

4. Unveil Intrahepatic Cholangiocarcinoma Heterogeneity through the Lens of Omics and Multi-Omics Approaches;Cancers;2024-08-20

5. Computational biophysical characterization of the effect of gatekeeper mutations on the binding of ponatinib to the FGFR kinase;Archives of Biochemistry and Biophysics;2024-08